Navigation Links
Alaris system

ProductsAlaris system
Company ALARIS Medical Systems, Inc.
Item Alaris system
Features Anesthesia/OR
  • Key-press audio "clicks" turned off
  • Additional OR drugs and OR-only limits
  • Anesthesia Mode becomes disabled when the device is disconnected from AC power and reverts back to the original profile for additional safety
  • Indefinite channel pause with no call-back
  • All limits for the safety software are set to "soft"

    NICU/PICU

  • Exceptional rate accuracy (+/- 2%)
  • Flow rates from 0.01 mL/hr to 999 mL/hr
  • Compatible with a wide range of syringes and brands
  • Unique and unmatched pressure-monitoring capabilities
  • Intuitive syringe-loading process

    Pain management

  • Built-in safety check for every PCA delivery, including pre-filled and pharmacy filled drugs
  • Customizable drug library for all care areas
  • Ability to combine PCA, large-volume pump and patient monitoring into one compact platform with a single user interface
  • Combined PCA-dosing history and SpO2 or EtCO2* values on a single platform
  • Industry leading Nellcor, Masimo and Oridion monitoring technologies available
  • First-of-its-kind CQI results for pain management process improvement

    Med surg/general ward

  • Modular platform standardizes devices throughout the hospital
  • Earlier identification of programming errors, before a medication error can occur
  • Smart infusion technology for a care area often overlooked when it comes to cutting-edge technology

    Oncology

  • Ability to schedule multiple-dose therapies based on the optimum times for each particular patient
  • Configurable with a variety of disposable set options including DEHP-free sets, secondary sets and manifold sets
  • Easy to ambulate

    Critical care

  • Ability to add or subtract modules as needed
  • Single interface for simplified training
  • Vertical alignment of channel lines for easy view
  • Single battery and power cord for up to 4 channels
  • Unmatched flexibility in customizing drug limits, with up to 1,000 drug and care applications
  • Description The Alaris System integrates drug infusion with patient monitoring and clinical best practice guidelines into a single, modular platform. With multiple configuration options, you can add or remove modules as you need them, keeping the number of devices at the bedside to a minimum while managing the unique needs of each patient.

    While the Alaris System offers maximum flexibility, it also incorporates a common user interface and alert system across multiple bedside devices, enabling you to standardize your infusion and monitoring systems across all areas of the hospital. We offer you a systems approach for all your care areas, rather than simply applying a new technology to "pockets of your facility. The modularity of this medication safety system also assists in effective asset utilization throughout the hospital.

    The Alaris System works with you to standardize best practices for medication safety from individual care areas to each specific patient.

    Info ALARIS Medical Systems, Inc.
    Customer Service: 800-854-7128
    Web site: http://www.alarismed.com/

    Related medicine products :

    1. SuperVu 2.5x Galilean system
    2. SuperVu 2.0x Galilean system
    3. SuperVu 3.0x Galilean system
    4. Catalyst system
    5. Headband headlight system
    6. Sweatband headlight system
    7. Headband headlight system (10-75 mm variable spot)
    8. Headband headlight system (100 mm fixed spot)
    9. IMx system
    10. TDx system
    11. Long system Ventriculoscope
    9mm Curved Blades with Sharp Pointed Tips; overall length 90mm; Stainless Steel....
    3 Gently Curved Prongs, 5mm extended, Stainless Steel Tips; with titanium handle....
    Straight shafts with fine Pierse type tips on a 5mm platform; In Titanium...
    Straight shaft; a 5mm platform with 0.3mm 1x2 teeth; In Titanium....
    Medicine Products:
    (Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... as the number one best large hotel for families in ... for their annual Travelers’ Choice Awards. , TripAdvisor represents ... is home to millions of unbiased and honest traveler reviews. ...
    (Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
    (Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
    (Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
    Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
    ... Boys with asthma who are exposed to environmental tobacco ... other behavioral problems, according to researchers at Cincinnati Children,s ... ahead of print by the Journal of Developmental ... increase along with higher exposure levels, but they added ...
    ... Transgenomic,(OTC Bulletin Board: TBIO) today announced ... Texas through its technology transfer entity, the,Research ... exclusive license,to patents covering a method for ... the basis for the development of diagnostic ...
    ... - Over 11,000 people raced to wellness in Louisiana ... challenge event was the latest in a series of programs ... is part of a growing movement to help people live ... one of the country,s most obese states, Louisiana is continuing ...
    ... (Dec. 4, 2008) In a statewide survey of ... Research Institute at Harbor-UCLA Medical Center (LA BioMed) are ... according to the December issue of Los Angeles magazine. ... more than 30,000 medical professionals to compile the 2008 ...
    ... released the following statement in reaction to the latest Congressional ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ) , ... that will only get worse if we allow America,s biggest ... these corporations go under -- taking with them the men ...
    ... division of Patient Safety Technologies, Inc. (OTC Bulletin Board:,PSTX), today ... become,one of its partners in helping to create a safer, ... at Leapfrog,s next two meetings in,December and February. , ... privileged to enter into an affiliation with,Leapfrog. We share a ...
    Cached Medicine News:Health News:Study strengthens link between tobacco smoke and behavioral problems in boys with asthma 2Health News:Study strengthens link between tobacco smoke and behavioral problems in boys with asthma 3Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 2Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 3Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 4Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 5Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 6Health News:High Tech Wellness Inspires Louisiana 2Health News:LA BioMed researchers among Southern California Super Doctors 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 3Health News:SurgiCount Medical Joins The Leapfrog Group 2
    (Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
    (Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
    (Date:1/23/2015)... N.J. , Jan. 23, 2015  CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce ... announced the receipt of $385,642, net of transaction ... of the Technology Business Tax Certificate Transfer Program ...
    Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3